Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

2017-2022 of 2022 results
Page 169 of 169
Key Publications August 30, 2007

Genetics of apolipoprotein B and apolipoprotein A1 and premature cardiovascular disease.

J Internal Med 2006;259:473-80

Zambon A, Brown BG, Deeb S, Brunzell JD
Cardiovascular Disease Genetics Lipids/Lipoproteins
Key Publications August 30, 2007

Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.

Arch Intern Med 2005;165:2479-84

Ballantyne CM, Hoogeveen RC, Bang H et al.
Inflammation Lipids/Lipoproteins
Key Publications August 30, 2007

Genetically determined apo B levels and peak LDL density angiographic response to intensive lipid-lowering therapy.

J Internal Med 2006;259:401-9

Zambon A, Brown BG, Hokanson JE, Motulsky AG, Brunzell JD
Lipids/Lipoproteins
Key Publications August 30, 2007

Small, dense LDL (sdLDL) and elevated apo B are the common characteristics for the 3 major lipid phenotypes of FCHL.

Arterioscler Thromb Vasc Biol 2003;23:1289-94

Ayyobi AF, McGladdery SH, McNeely MJ, Austin MA, Motulsky AG, Brunzell JD
Lipids/Lipoproteins
Key Publications August 30, 2007

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

J Intern Med 2006;259:247-58

Barter PJ, Ballantyne CM, Carmena R et al.
Lipids/Lipoproteins
Key Publications August 30, 2007

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

J Clin Invest 2005;115:1298-305

Osei-Hyiaman D, DePetrillo M, Pacher P et al.
Lipids/Lipoproteins Metabolism: Animal Studies Obesity
of 169